Dechra Pharmaceuticals PLC is an England-based business involved in the development and marketing of veterinary products. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
The Company was founded in 1997 by way of a management buy-out from Lloyds Chemists. It was first listed on the London Stock Exchange in 2000. In 2007 it bought VetXX, a Danish veterinary products business, for £62 million. In 2010 it purchased Florida-based DermaPet for US$64 million and...